Photo Credit: Hill Research
Hill Research Chief Revenue Officer David A. Hall was scheduled to speak on AI and cancer detection at the 2026 NFCR Global Summit, hosted by the National Foundation for Cancer Research (NFCR) on October 9, 2026, at the National Press Club in Washington, DC. Hill Research CEO Dr. Louise Liu also planned to attend.
AI and Cancer Detection Panel at the NFCR Global Summit
Hall was slated for Panel I, AI and Cancer Detection, moderated by Funmi Olopade, M.D., of University of Chicago Medicine. Fellow panelists included Bill Lotter, Ph.D., of Dana-Farber Cancer Institute; Shweta Maniar of Google Cloud; and Eytan Ruppin, M.D., Ph.D., of Cedars-Sinai Medical Center.
The 2026 NFCR Global Summit centered on artificial intelligence in cancer research, early detection, and precision medicine. Its program included a keynote from Bruce Beutler, M.D., 2011 Nobel Laureate in Physiology or Medicine, and a talk from Doug Lowy, M.D., Deputy Director of the National Cancer Institute.
From Cancer Detection to Clinical Development
Hill Research sees cancer detection as AI’s most visible promise and clinical development as where that promise must hold up, with traceable results, reproducible analyses, and outputs ready for regulatory review. That is the setting its TriClick™ platform is built for.
Who Is David A. Hall?
Hall brings three decades of experience across AI, healthcare, and public service, including service as a U.S. Army officer and Peace Corps Volunteer. Through the DPPC InnovaHub, he has trained more than 100 physician innovators across 13 countries.
About Hill Research
Princeton, New Jersey-based Hill Research is an AI-powered clinical research company and a Jetstream Venture Fund portfolio company. Its TriClick™ platform turns raw clinical trial data into regulatory-ready outputs with human oversight.
Frequently Asked Questions
What is the NFCR Global Summit?
The NFCR Global Summit and Award Ceremonies for Cancer Research & Entrepreneurship is hosted by the National Foundation for Cancer Research. It gathers leaders from academia, industry, technology, government, investment, and patient advocacy, and its 2026 program focused on AI in cancer research.
Who represented Hill Research at the 2026 NFCR Global Summit?
Hill Research Chief Revenue Officer David A. Hall was scheduled to speak on Panel I, AI and Cancer Detection, on October 9, 2026, in Washington, DC. Hill Research CEO Dr. Louise Liu also planned to attend the summit.
Read the Original Article: Hill Research’s David A. Hall to Speak on AI and Cancer Detection at the 2026 NFCR Global Summit